(Q51489373)

5 April 2018

title

BMI modifies associations of IL-6 genotypes with insulin resistance: the Framingham Study. (English)

1 reference

5 April 2018

1 reference

1 reference

8

1 reference

5 April 2018

James B. Meigs

7

object named as

James B Meigs

1 reference

5 April 2018

5

Alisa Manning

1 reference

5 April 2018

Caroline S. Fox

6

object named as

Caroline S Fox

1 reference

5 April 2018

author name string

Alan Herbert

1

1 reference

5 April 2018

Chunyu Liu

2

1 reference

5 April 2018

Samer Karamohamed

3

1 reference

5 April 2018

Jun Liu

4

1 reference

5 April 2018

publication date

1 August 2006

1 reference

5 April 2018

published in

Obesity

1 reference

5 April 2018

volume

14

1 reference

5 April 2018

page(s)

1454-1461

1 reference

5 April 2018

issue

8

1 reference

5 April 2018

Importance of identifying the overweight patient who will benefit the most by losing weight

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

An adipocentric view of signaling and intracellular trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Interleukin-6 gene polymorphism and insulin sensitivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Interleukin-6 induces cellular insulin resistance in hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Parental transmission of type 2 diabetes: the Framingham Offspring Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Diagnosing insulin resistance in the general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

31 March 2020

Sex steroids and bone

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Smad4 as a transcription corepressor for estrogen receptor alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Interleukin-6: the endocrine cytokine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

Population stratification and spurious allelic association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

inferred from DOI database lookup

7 January 2021

based on heuristic

An investigation of coronary heart disease in families. The Framingham offspring study

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.165

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2006.165

1 reference

5 April 2018

PubMed ID

16988089

1 reference

5 April 2018